assay
>99% (TLC)
form
chloroform solution
packaging
pkg of 2 × 20 mL (100500C-1g), pkg of 1 × 4 mL (100500C-100mg), pkg of 5 × 4 mL (100500C-500mg)
manufacturer/tradename
Avanti Research™ - A Croda Brand
concentration
25 mg/mL (100500C-100mg), 25 mg/mL (100500C-1g), 25 mg/mL (100500C-500mg)
lipid type
lipid extracts
shipped in
dry ice
storage temp.
−20°C
General description
This product is an extract of E. coli B (ATCC 11303) grown in Kornberg Minimal media at 37°C and taken at 3/4 log growth phase. Total E. coli lipid extract is a chloroform:methanol extract of the respective tissue. This extract is partitioned against deionized water and the chloroform phase is concentrated.
Application
E. coli Extract Total is suitable:
- for solubilization of His6-tagged wtABCG2 and its steroid-binding element (SBE) mutant variants
- to prepare E. coli liposomes for liposomal content release assay
- for the determination of the phospholipid types bound to purified AdiC in DDM (n-dodecyl-β-D-maltopyranoside) and OM (n-octyl-β-D-maltopyranoside)
E. coli extract total has been used for the preparation of liposomes. It has also been used to characterize the ternary complexes obtained after purification of membrane proteins in different detergents.
E. coli Extract Total has been used:
- in the preparation of small unilamellar vesicles (SUVs)
- as a reference standard in electrospray ionization tandem mass spectrometry (ESI-MS/MS)
- in the reconstitution of ATP-binding cassette (ABC) transporter for electron paramagnetic resonance spectroscopy studies
Biochem/physiol Actions
The E.coli lipid extract contains phosphatidylethanolamine, phosphatidylglycerol and cardiolipin. The E. coli lipid extract serves as a standard for profiling phospholipids, aids in the identification and taxonomic grouping of any bacterial sample. It is also used for preparing supported lipid bilayers.
Packaging
30 mL Amber Narrow Mouth Glass Bottle with Screw Cap (100500C-1g)
5 mL Clear Glass Sealed Ampule (100500C-100mg)
5 mL Clear Glass Sealed Ampule (100500C-500mg)
Legal Information
Avanti Research is a trademark of Avanti Polar Lipids, LLC
signalword
Danger
Hazard Classifications
Acute Tox. 3 Inhalation - Acute Tox. 4 Oral - Aquatic Chronic 3 - Carc. 2 - Eye Irrit. 2 - Repr. 2 - Skin Irrit. 2 - STOT RE 1 - STOT SE 3
target_organs
Central nervous system, Liver,Kidney
wgk
WGK 3
저장 등급
6.1D - Non-combustible acute toxic Cat.3 / toxic hazardous materials or hazardous materials causing chronic effects
flash_point_f
does not flash
flash_point_c
does not flash
Variation of the Detergent-Binding Capacity and Phospholipid Content of Membrane Proteins When Purified in Different Detergents
Ilgu H, et al.
Biophysical Journal, 106, 1660-1670 (2014)
Regulation of the Function of the Human ABCG2 Multidrug Transporter by Cholesterol and Bile Acids: Effects of Mutations in Potential Substrate and Steroid Binding Sites
Telbisz A, et al.
Drug Metabolism and Disposition, 42(4), 575?585-575?585 (2014)
GhoT of the GhoT/GhoS toxin/antitoxin system damages lipid membranes by forming transient pores
Kim JS, et al.
Biochemical and biophysical research communications, 467-472 (2018)
국제 무역 품목 번호
| SKU | GTIN |
|---|---|
| 100500C-100MG | 04061838168955 |
| 100500C-1G | 04061838168962 |
| 100500C-500MG | 04061838168979 |